PRED Drug Patent Profile
✉ Email this page to a colleague
When do Pred patents expire, and what generic alternatives are available?
Pred is a drug marketed by Abbvie, Allergan, Pharmafair, Epic Pharma Llc, Fougera Pharms, Schwarz Pharma, Chartwell Rx, Hikma, Ivax Sub Teva Pharms, Lannett Co Inc, Nesher Pharms, Pharm Assoc, Pharmobedient Cnsltg, Teva Pharms, Tp Anda Holdings, We Pharms, Aurobindo Pharma Ltd, Barr, Bundy, Chartwell Molecular, Elkins Sinn, Everylife, Ferrante, Fosun Pharma, Heather, Impax Labs, Inwood Labs, Marshall Pharma, Panray, Phoenix Labs Ny, Purepac Pharm, Pvt Form, Rising, Roxane, Sperti, Superpharm, Tablicaps, Teva, UDL, Valeant Pharm Intl, Vitarine, Watson Labs, West Ward, Whiteworth Town Plsn, Zhejiang Xianju, Bel Mar, Cent Pharms, Amneal, Lupin, Alcon Pharms Ltd, Bausch And Lomb, Sola Barnes Hind, Amneal Pharms, Bausch, Edenbridge Pharms, Mission Pharma, Ph Health, Pharmobedient, Vintage Pharms, Xttrium Labs Inc, Actavis Labs Fl Inc, Dr Reddys, Aiping Pharm Inc, Am Therap, Amneal Pharms Ny, Contract Pharmacal, Duramed Pharms Barr, Geneyork Pharms, Halsey, Hikma Pharms, Jubilant Cadista, Kv Pharm, Lederle, Mutual Pharm, Mylan, Novitium Pharma, Nylos, Pharmavite, Pointview Hldings, Rexall, Scherer Labs, Strides Pharma, Sun Pharm Industries, Upsher Smith, and Vangard. and is included in two hundred and twelve NDAs.
The generic ingredient in PRED is prednisolone tebutate. There are eighty-eight drug master file entries for this compound. Additional details are available on the prednisolone tebutate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PRED?
- What are the global sales for PRED?
- What is Average Wholesale Price for PRED?
Summary for PRED
| US Patents: | 0 |
| Applicants: | 85 |
| NDAs: | 212 |
| Drug Prices: | Drug price information for PRED |
| Drug Sales Revenues: | Drug sales revenues for PRED |
| DailyMed Link: | PRED at DailyMed |
US Patents and Regulatory Information for PRED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | PREDNISOLONE ACETATE | prednisolone acetate | INJECTABLE;INJECTION | 083767-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Strides Pharma | PREDNISONE | prednisone | TABLET;ORAL | 208412-001 | Feb 11, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharm Assoc | PREDNISOLONE SODIUM PHOSPHATE | prednisolone sodium phosphate | SOLUTION;ORAL | 076123-001 | Dec 23, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Udl | PREDNISONE | prednisone | TABLET;ORAL | 087986-001 | Jan 18, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
